LO read from the Dutton report how CYGX is unique compared to RNA.We have a DNA delivery system.
Because CytoGenix's technology controls gene expression from inside the cell, we believe the Company may be capable of developing therapeutic products that circumvent these problems. We also believe that CytoGenix is a technology leader among the handful of companies developing therapeutics around ODN technology.
This is The second have of the Dutton report that you have over looked.And you seem to have basher vision .
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.